Concr CEO Irina Babina and CTO Matthew Griffiths unpack how Bayesian foundation models can excel at uncertainty management to ...
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more flexible, data-driven approaches that integrate prior knowledge, reduce sample ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results